Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib. [electronic resource]
Producer: 20170623Description: 606-16 p. digitalISSN:- 1096-8652
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Aniline Compounds -- therapeutic use
- Cardiotoxicity -- etiology
- Female
- Humans
- Hypercholesterolemia
- Hyperlipidemias
- Imatinib Mesylate -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- complications
- Male
- Middle Aged
- Nitriles -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Quinolines -- therapeutic use
- Retrospective Studies
- Risk Factors
- Vascular Diseases -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.